Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by Streptococcus pneumoniae; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; and Nexterone, a captisol-enabled formulation of amiodarone; and Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners and licenses programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver and kidney disease, and other diseases. Further, it sells Captisol materials. The company was incorporated in 1987 and is headquartered in Emeryville, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Ligand Pharmaceuticals Incorporated.
Ligand Pharmaceuticals Incorporated business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Ligand Pharmaceuticals Incorporated are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Ligand Pharmaceuticals Incorporated , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Ligand Pharmaceuticals Incorporated including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Ligand Pharmaceuticals Incorporated and all latest updates of the company are provided.
The 2025 version of Ligand Pharmaceuticals Incorporated report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Ligand Pharmaceuticals Incorporated- Key Facts
2.2 Ligand Pharmaceuticals Incorporated- Geographic Locations
2.3 Ligand Pharmaceuticals Incorporated- Subsidiaries and Affiliates
2.4 Ligand Pharmaceuticals Incorporated- Business Divisions
2.5 Ligand Pharmaceuticals Incorporated- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Ligand Pharmaceuticals Incorporated Strategic Analysis Review
3.1 Ligand Pharmaceuticals Incorporated- Key Strategies
3.2 Ligand Pharmaceuticals Incorporated- Company Outlook Statement
3.3 Ligand Pharmaceuticals Incorporated- SWOT Analysis
3.3.1 Ligand Pharmaceuticals Incorporated- Key Strengths
3.3.2 Ligand Pharmaceuticals Incorporated- Key Weaknesses
3.3.3 Ligand Pharmaceuticals Incorporated- Potential Opportunities
3.3.4 Ligand Pharmaceuticals Incorporated- Potential Threats
3.4 Ligand Pharmaceuticals Incorporated- Key Competitors
4. Business Description of the Company
4.1 Ligand Pharmaceuticals Incorporated- Business Overview
4.2 Ligand Pharmaceuticals Incorporated- Operations by Segment
5 Products and Services Details
5.1 Ligand Pharmaceuticals Incorporated- Key Products
5.2 Ligand Pharmaceuticals Incorporated- Key Service Areas
5.3 Ligand Pharmaceuticals Incorporated- Key Brands
6 Company Developments
6.1 Ligand Pharmaceuticals Incorporated- Company History
6.2 Ligand Pharmaceuticals Incorporated- Latest Developments
7 Financial Analysis
7.1 Ligand Pharmaceuticals Incorporated- Income Statements
7.2 Ligand Pharmaceuticals Incorporated- Balance Sheet
7.3 Ligand Pharmaceuticals Incorporated- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Ligand Pharmaceuticals Incorporated- Direct Competitors
8.2 Ligand Pharmaceuticals Incorporated- Competitor Financial Ratios comparison
8.3 Ligand Pharmaceuticals Incorporated- Competitor Stock Charts Comparison
8.4 Ligand Pharmaceuticals Incorporated- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!